Additionally, participants with dyslipidemia were older (50.13 ± 0.28 years vs. 40.21 ± 0.36 years), with a higher CRP (0.44 ± 0.02 mg/L vs. 0.31 ± 0.01 mg/L) and likelihood for comorbidities (hypertension, DM, CAD, CHF, stroke, and cancer). This evidence concerns the gene CRP and Hypertension.